期刊
ACS BIOMATERIALS SCIENCE & ENGINEERING
卷 6, 期 7, 页码 4077-4086出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.0c00591
关键词
salmon calcitonin; thermosensitive hydrogel; long-term release; osteogenic response
资金
- National Natural Science Foundation of China [51925304, 21534008, 51703138, 51773128]
- Department of Science and Technology of Sichuan Province [2019JDRC0090]
- China Postdoctoral Science Foundation [2018M633368]
The common pathological characteristic of osteoporosis and hypercalcemia is the disorder of calcium homeostasis. Currently, salmon calcitonin (sCT), a clinical regenerative medicine, is an attractive chioice to regulate calcium metabolism for alleviation of osteoporosis and hypercalcemia. Unfortunately, serum sCT is quickly cleared in vivo, leading to its short half-life. Here, we designed a versatile hydrogel, based on salmon calcitonin-oxidized calcium alginate (sCT-OCA) conjugate and hydroxypropyl chitin (HPCH). The release profile showed that sCT could be released from HPCH hydrogels loaded with sCT-OCA conjugate (sCT-OCA-HPCH) for at least 28 days with conformation stability. The cellular test demonstrated that the biocompatible sCT-OCA-HPCH, compared with sCT formulation, had capacity in up-regulating alkaline phosphatase activity (similar to 63% increase) and promoting calcium to deposit into extracellular matrix (similar to 42% increase). These results indicated that thermosensitive sCT-OCA-HPCH hydrogel herein is a versatile platform for many applications such as calcium metabolism regulation, osteoporosis treatment, and hypercalcemia therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据